We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A Virginia-based biotech company has announced dosing of ...

In a recent study published in Respiratory Medicine, researchers reported that silent hypoxia was not unique to coronavirus disease 2019 (COVID-19). Silent hypoxemia syndrome, well-tolerated hypoxemia ...

NORFOLK, Va.--(BUSINESS WIRE)--ReAlta Life Sciences (“ReAlta”), Inc., a clinical mid-stage biotech company dedicated to addressing life-threatening rare diseases by harnessing the power of the immune ...

Synaptic injury in the IPL of the retina is linked to MS progression, with IPL thickness as a potential biomarker. Hypoxia in MS patients exacerbates inflammation and mitochondrial damage, ...

Moderate to severe nocturnal hypoxemia is linked to lower cardiovascular event rates in patients with acute coronary syndrome and OSA.

The combination of a vascular endothelial growth factor (VEGF) –neutralizing antibody, bevacizumab, and irinotecan is associated with high radiographic response rates and improved survival outcomes in ...

Results of a VHIO led study show that up to 90% of chronically hypoxic patients have an EPAS1 alteration in their tumor, a gene critical for adapting to lack of oxygen in populations living at ...

Roots Community Health Center was slammed in 2020, with lines for its COVID-19 testing stations stretching around the block and exam rooms full of people struggling to breathe. Patient after patient ...